Literature DB >> 10510316

Metabolic adaptations to dietary fat malabsorption in chylomicron-deficient mice.

H R Jung1, S M Turner, R A Neese, S G Young, M K Hellerstein.   

Abstract

A mouse model of chylomicron deficiency was recently developed; these mice express a human apolipoprotein (apo) B transgene in the liver but do not synthesize any apoB in the intestine. Despite severe intestinal fat malabsorption, the mice maintain normal concentrations of plasma lipids and liver-derived apoB 100-containing lipoproteins. We investigated the metabolic mechanisms by which plasma lipid levels are kept normal. De novo lipogenesis (DNL) and cholesterogenesis were measured by mass isotopomer distribution analysis (MIDA). Plasma non-esterified fatty acid (NEFA) fluxes and hepatic re-esterification of labelled plasma NEFA were also measured. Hepatic and plasma triacylglycerol (TG) concentrations and plasma NEFA fluxes were not different between chylomicron-deficient mice and controls. The contribution from DNL to the hepatic TG pool was only modestly higher in chylomicron-deficient mice [12+/-2.1% (n=7) compared with 3.7+/-1.0% (n=9); means+/-S.E.M.], whereas cholesterogenesis was markedly elevated. The fractional contribution from plasma NEFA to hepatic TG was greatly elevated in the chylomicron-deficient animals (62% compared with 23%). Accordingly, 73% of hepatic TG was neither from DNL nor from plasma NEFA in controls, presumably reflecting prior contribution from chylomicron remnants, compared with only 26% in the chylomicron-deficient group. The long-term contribution from DNL to adipose fat stores reached approximately the same steady-state values (approximately 30%) in the two groups. Body fat accumulation was much lower in chylomicron-deficient animals; thus, whole-body absolute DNL was significantly lower. We conclude that plasma and hepatic TG pools and hepatic secretion of apoB-containing particles are maintained at normal levels in chylomicron-deficient mice, not by de novo fatty acid synthesis, but by more avid re-esterification of plasma NEFA, replacing the normally predominant contribution from chylomicrons, and that some dietary fat can be absorbed by apoB-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10510316      PMCID: PMC1220577     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  A genetic model for absent chylomicron formation: mice producing apolipoprotein B in the liver, but not in the intestine.

Authors:  S G Young; C M Cham; R E Pitas; B J Burri; A Connolly; L Flynn; A S Pappu; J S Wong; R L Hamilton; R V Farese
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

2.  Absorption and metabolism of [3H]arachidonic and [14C]linoleic acid in essential fatty acid-deficient rats.

Authors:  L Hjelte; T Melin; A Nilsson; B Strandvik
Journal:  Am J Physiol       Date:  1990-07

3.  A simple method for carcass analysis.

Authors:  A I Leshner; V A Litwin; R L Squibb
Journal:  Physiol Behav       Date:  1972-08

4.  Sampling the lipogenic hepatic acetyl-CoA pool in vivo in the rat. Comparison of xenobiotic probe to values predicted from isotopomeric distribution in circulating lipids and measurement of lipogenesis and acetyl-CoA dilution.

Authors:  M K Hellerstein; K Wu; S Kaempfer; C Kletke; C H Shackleton
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

5.  Measurement of de novo hepatic lipogenesis in humans using stable isotopes.

Authors:  M K Hellerstein; M Christiansen; S Kaempfer; C Kletke; K Wu; J S Reid; K Mulligan; N S Hellerstein; C H Shackleton
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

6.  Measurement of plasma free fatty acid turnover and oxidation using [1-13C]palmitic acid.

Authors:  R R Wolfe; J E Evans; C J Mullany; J F Burke
Journal:  Biomed Mass Spectrom       Date:  1980-04

7.  Studies on the absorptive defect for triglyceride in abetalipoproteinemia.

Authors:  P O Ways; C M Parmentier; H J Kayden; J W Jones; D R Saunders; C E Rubin
Journal:  J Clin Invest       Date:  1967-01       Impact factor: 14.808

8.  Portal venous transport of long-chain fatty acids absorbed from rat intestine.

Authors:  G B McDonald; D R Saunders; M Weidman; L Fisher
Journal:  Am J Physiol       Date:  1980-09

Review 9.  Hepatic synthesis of lipoproteins and apolipoproteins.

Authors:  J L Dixon; H N Ginsberg
Journal:  Semin Liver Dis       Date:  1992-11       Impact factor: 6.115

Review 10.  Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers.

Authors:  M K Hellerstein; R A Neese
Journal:  Am J Physiol       Date:  1992-11
View more
  12 in total

1.  Liquid chromatography-high resolution mass spectrometry analysis of fatty acid metabolism.

Authors:  Jurre J Kamphorst; Jing Fan; Wenyun Lu; Eileen White; Joshua D Rabinowitz
Journal:  Anal Chem       Date:  2011-11-04       Impact factor: 6.986

2.  Nocturnin regulates circadian trafficking of dietary lipid in intestinal enterocytes.

Authors:  Nicholas Douris; Shihoko Kojima; Xiaoyue Pan; Alexandra F Lerch-Gaggl; Son Q Duong; M Mahmood Hussain; Carla B Green
Journal:  Curr Biol       Date:  2011-08-04       Impact factor: 10.834

3.  Effects of triacylglycerol structure and solid fat content on fasting responses of mice.

Authors:  Xiaosan Wang; Tong Wang; Michael E Spurlock; Xingguo Wang
Journal:  Eur J Nutr       Date:  2015-07-04       Impact factor: 5.614

4.  Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL.

Authors:  A K Groen; V W Bloks; R H Bandsma; R Ottenhoff; G Chimini; F Kuipers
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 5.  Effects of Lipid Structure Changed by Interesterification on Melting Property and Lipemia.

Authors:  Tong Wang; Xiaosan Wang; Xingguo Wang
Journal:  Lipids       Date:  2016-08-24       Impact factor: 1.880

6.  FXR overexpression alters adipose tissue architecture in mice and limits its storage capacity leading to metabolic derangements.

Authors:  Tim van Zutphen; Johanna H M Stroeve; Jiufang Yang; Vincent W Bloks; Angelika Jurdzinski; Han Roelofsen; Nicolette C A Huijkman; Theo H van Dijk; Roel J Vonk; Jan van Deursen; Bart Staels; Albert K Groen; Folkert Kuipers
Journal:  J Lipid Res       Date:  2019-06-28       Impact factor: 5.922

7.  Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice.

Authors:  S M Turner; S Roy; H S Sul; R A Neese; E J Murphy; W Samandi; D J Roohk; M K Hellerstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-12-12       Impact factor: 4.310

8.  Dexamethasone-mediated changes in adipose triacylglycerol metabolism are exaggerated, not diminished, in the absence of a functional GR dimerization domain.

Authors:  Donald J Roohk; Smita Mascharak; Cyrus Khambatta; Ho Leung; Marc Hellerstein; Charles Harris
Journal:  Endocrinology       Date:  2013-03-14       Impact factor: 4.736

9.  Large increases in adipose triacylglycerol flux in Cushingoid CRH-Tg mice are explained by futile cycling.

Authors:  Charles Harris; Donald J Roohk; Mark Fitch; Benjamin M Boudignon; Bernard P Halloran; Marc K Hellerstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-04       Impact factor: 4.310

10.  Numerous transcriptional alterations in liver persist after short-term enzyme-replacement therapy in a murine model of mucopolysaccharidosis type VII.

Authors:  Josh C Woloszynek; Marie Roberts; Trey Coleman; Carole Vogler; William Sly; Clay F Semenkovich; Mark S Sands
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.